Status:
WITHDRAWN
Low Dose Ketamine Infusion for the Treatment of Resistant Depression
Lead Sponsor:
Loma Linda University
Collaborating Sponsors:
Sarah Capalla
Ebony HIllery
Conditions:
Depression
Eligibility:
All Genders
18-89 years
Brief Summary
The purpose of this investigator-initiated observational study is to examine how low Ketamine infusion treatments impact antidepressant and anti-suicidal effects for refractory and non-refractory depr...
Detailed Description
This is a descriptive research study that will be collecting prospective outcome data in patients who have been examined Psychiatry and the Intensive Care Unit attending. This study will follow the pa...
Eligibility Criteria
Inclusion
- treatment resistant depression
Exclusion
- Patients excluded by SICU/ER attending for treatment based on the following relative contraindications:
- Coronary artery disease
- Increased intraocular pressure (glaucoma)
- Increased intracranial pressure
- Uncontrolled hypertension
- Kidney dysfunction
- Liver dysfunction
- Cardiac decompensation
- Psychotic disorders (needs further evaluation)
Key Trial Info
Start Date :
June 29 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 29 2020
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT04283058
Start Date
June 29 2020
End Date
December 29 2020
Last Update
May 1 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Loma Linda University Medical Center
Loma Linda, California, United States, 92354